statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gagnants
L'action Kineta (NASDAQ:KA) a mont lundi de 16,77% 0,63 dollars lors de la session after-market.
Le titre Windtree Therapeutics (NASDAQ:WINT) a mont de 14,63% 0,47 dollars.
Le titre...

12 titres de soins de sant  en mouvement lors de la session apr s-cl ture le 08/04/2024

Windtree Therapeutics, Inc. (NASDAQ:WINT  Get Free Report) was the recipient of a significant decrease in short interest in February. As of February 15th, there was short interest totalling...

Windtree Therapeutics, Inc. (NASDAQ:WINT) Short Interest Down 56.0% in February

Windtree Therapeutics, Inc. (NASDAQ:WINT  Get Free Report) saw a large decrease in short interest in the month of February. As of February 15th, there was short interest totalling 101,100...

Windtree Therapeutics, Inc. (NASDAQ:WINT) Sees Large Decline in Short Interest

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Windtree Therapeutics files to sell 608,272 shares of common stock for holders

Craig Fraser, CEO of Windtree Therapeutics, Inc. (NASDAQ: WINT), was recently interviewed by Benzinga.
Windtree is advancing late-stage interventions for cardiovascular disorders to treat patients in...

Windtree Therapeutics   This Biotech Inks License Deal For Lead Candidate

WARRINGTON, PA / ACCESSWIRE / January 26, 2024 / Windtree Therapeutics (NASDAQ:WINT) announced an agreement with affiliates of biopharma investor Deerfield Management Company to fully retire a $15...

Windtree Therapeutics (NASDAQ:WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company

Windtree Therapeutics (NASDAQ: WINT) announced an agreement with affiliates of biopharma investor Deerfield Management Company to fully retire a $15 million contingent liability associated with...

Windtree Therapeutics (NASDAQ: WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company

WARRINGTON, PA / ACCESSWIRE / January 18, 2024 / Greater China holds a significant, if not the world's largest, acute heart failure patient population. It may be a market where drug treatment...

Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China

Windtree Therapeutics announces license agreement with Lee's Pharmaceuticals

HC Wainwright assumed coverage on shares of Windtree Therapeutics (NASDAQ:WINT  Free Report) in a research report report published on Wednesday, Benzinga reports. The firm issued a neutral...

Windtree Therapeutics (NASDAQ:WINT) Research Coverage Started at HC Wainwright

Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.

Volume	28,473.00
52-Wk High	$35.10
52-Wk Low	$4.78

WINT Windtree Therapeutics Inc

About

Feed

News

Sentiment

Fundamentals